Guo-le Lin

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Prognostic impact of tumour deposits across N stages in stage III colon cancer: development and validation of a novel N staging system using the SEER database and a Chinese single-centre cohort.

Prognostic impact of tumour deposits across N stages in stage III colon cancer: development and validation of a novel N staging system using the SEER database and a Chinese single-centre cohort.

Journal: BMJ open

Published: February 26, 2026

Feasibility of ctDNA-guided precision neoadjuvant therapy in locally advanced rectal cancer: Insights from the ongoing CINTS-R trial.

Feasibility of ctDNA-guided precision neoadjuvant therapy in locally advanced rectal cancer: Insights from the ongoing CINTS-R trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 09, 2025

Clinical characteristics and survival outcomes of rectal cancer patients across different mrT3 substages determined by rectal MRI.

Clinical characteristics and survival outcomes of rectal cancer patients across different mrT3 substages determined by rectal MRI.

Journal: International journal of colorectal disease

Published: June 07, 2025

CapeOX Versus Capecitabine in Neoadjuvant Chemoradiation for High-Risk Locally Advanced Rectal Cancer: Long-Term Results From the MONT-R Randomized Controlled Trial.

CapeOX Versus Capecitabine in Neoadjuvant Chemoradiation for High-Risk Locally Advanced Rectal Cancer: Long-Term Results From the MONT-R Randomized Controlled Trial.

Journal: International journal of radiation oncology, biology, physics

Published: March 05, 2025

Rationale and design of a multicentre randomised controlled trial on circulating tumour DNA-guided neoadjuvant treatment strategy for locally advanced rectal cancer (CINTS-R).

Rationale and design of a multicentre randomised controlled trial on circulating tumour DNA-guided neoadjuvant treatment strategy for locally advanced rectal cancer (CINTS-R).

Journal: BMJ open

Published: February 02, 2025

Predictive value of rectal MRI variables for pathological complete response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy.

Predictive value of rectal MRI variables for pathological complete response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy.

Journal: International journal of colorectal disease

Published: December 28, 2024

Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter study.

Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter study.

Journal: EBioMedicine

Published: October 20, 2024

Personalizing colorectal Cancer treatment: Chemotherapy drug testing with patient-derived tumor cell clusters.

Personalizing colorectal Cancer treatment: Chemotherapy drug testing with patient-derived tumor cell clusters.

Journal: Translational oncology

Published: September 22, 2024

A new treatment strategy for mid-low rectal cancer patients exhibiting a clinical complete or near-complete response to neoadjuvant chemoradiotherapy: Transanal endoscopic microsurgery --A multicenter prospective case-control clinical trial by MONT-R.

A new treatment strategy for mid-low rectal cancer patients exhibiting a clinical complete or near-complete response to neoadjuvant chemoradiotherapy: Transanal endoscopic microsurgery --A multicenter prospective case-control clinical trial by MONT-R.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 18, 2024

Clinical characteristics and survival outcomes of well-responders following definite comprehensive treatment in locally advanced rectal cancer.

Clinical characteristics and survival outcomes of well-responders following definite comprehensive treatment in locally advanced rectal cancer.

Journal: BMC cancer

Published: September 11, 2024

Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location.

Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location.

Journal: World journal of gastroenterology

Published: July 10, 2024

Hsa-miR-483-5p/mRNA network that regulates chemotherapy resistance in locally advanced rectal cancer identified through plasma exosome transcriptomics.

Hsa-miR-483-5p/mRNA network that regulates chemotherapy resistance in locally advanced rectal cancer identified through plasma exosome transcriptomics.

Journal: World journal of clinical oncology

Published: April 28, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026